UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001565
Receipt number R000001840
Scientific Title BS-POP validation study
Date of disclosure of the study information 2008/12/11
Last modified on 2010/06/18 09:46:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

BS-POP validation study

Acronym

BS-POP validation study

Scientific Title

BS-POP validation study

Scientific Title:Acronym

BS-POP validation study

Region

Japan


Condition

Condition

Chronic low back pain

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

prove the effectiveness of BS-POP

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

BS-POP
MMPI
POMS
SF-36
RDQ

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)A patient older than 20 years old at the agreement acquisition.
(2)VAS is longer than 40mm at the baseline observation.
(3)A duration of low back pain is more than three months.
(4)Major area of low back pain is lower than 12th thoracic vertebra.
(5)An adequate patients , who is decided by a doctor , for participation of this study.
(6)A patient conform a treatment plan and a planned hospital visit,and has vilition and ability for clinical inspections.
(7)A patient who consents and document to enroll this study before starting investigation.

Key exclusion criteria

(1)The presence of rheumatoid arthritis, spondyloarthropathy (e.g.,ankylosing spondylitis, psoriasis-related joint pain) with negative serum reaction, metastasis of tumors, Behcets disease, fibromyalgia, tumor or infection of the spinal cord or intervertebral disc , and a past history of other diseases of the sharp pain
(2)The presence of low back pain due to trauma within 6 months after registration(e.g.,vertebral fracture,pseudarthrosis,spondylarthropathy due to trauma).
(3)The presence of low back pain due to internal organs diseases.
(4)The presence of malignant tumor , or the past history of the malignant tumor.
(A patient who underwent surgical resection of malignant tumor or no recurrence cancer more than 5 years after registration.)
(5)A past history abuse of alchol , analgesic , and drugs.
(6)Inadequate patient,who is decided by a doctor,for participation or execution.
(7)Having relevance to traffic or occupational accidents.
(8)The past history of spinal surgery within six months.

Target sample size

280


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name shin-ichi konno

Organization

fukushima medical university

Division name

orthopedics

Zip code


Address

1, Hikarigaoka, Fukushima-shi, Fukushima

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

fukushima medical university

Division name

orthopedics

Zip code


Address


TEL


Homepage URL


Email

fortho@fmu.ac.jp


Sponsor or person

Institute

SGSP

Institute

Department

Personal name



Funding Source

Organization

fukushima medical university orthopedics

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 12 Month 11 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 11 Month 01 Day

Last follow-up date

2009 Year 07 Month 01 Day

Date of closure to data entry

2009 Year 10 Month 01 Day

Date trial data considered complete

2009 Year 10 Month 01 Day

Date analysis concluded

2010 Year 01 Month 01 Day


Other

Other related information

Observation ofrelation between BS-POP and MMPI


Management information

Registered date

2008 Year 12 Month 11 Day

Last modified on

2010 Year 06 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001840


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name